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ABSTRACT
Alus, primate-specific retroelements, are the most
abundant repetitive elements in the human genome.
They are composed of two related but distinct
monomers, left and right arms. Intronic Alu ele-
ments may acquire mutations that generate func-
tional splice sites, a process called exonization.
Most exonizations occur in right arms of antisense
Alu elements, and are alternatively spliced. Here we
show that without the left arm, exonization of the
right arm shifts from alternative to constitutive
splicing. This eliminates the evolutionary conserved
isoform and may thus be selected against. We
further show that insertion of the left arm down-
stream of a constitutively spliced non-Alu exon
shifts splicing from constitutive to alternative.
Although the two arms are highly similar, the left
arm is characterized by weaker splicing signals and
lower exonic splicing regulatory (ESR) densities.
Mutations that improve these potential splice sig-
nals activate exonization and shift splicing from the
right to the left arm. Collaboration between two or
more putative splice signals renders the intronic left
arm with a pseudo-exon function. Thus, the dimeric
form of the Alu element fortuitously provides it with
an evolutionary advantage, allowing enrichment of
the primate transcriptome without compromising its
original repertoire.
INTRODUCTION
Alternative splicing is a mechanism by which transcrip-
tomic diversity is generated from a relatively low number
of human protein-coding genes (1–3). An average human
gene is 28000-nt long and is composed of 8.8 exons of
 130 nucleotides each, separated by 7.8 introns of
 3000nt (3). Bioinformatic analyses estimate that >70%
of all human genes generate more than one isoform by
alternative splicing, which contributes signiﬁcantly to
human proteome complexity (4).
The splicing reaction involves the recognition of exon–
intron junctions by the spliceosome and intron excision
through a two-step transesteriﬁcation reaction (5–7).
The spliceosome is a large and dynamic complex assem-
bled from ﬁve small nuclear ribonucleoproteins (snRNPs)
and over 200 additional proteins (8–11). The spliceosome
recognizes four conserved sequences located at both ends
of introns: the 50 and 30 splice sites (50ss and 30ss), the
polypyrimidine tract (PPT) and the branch point sequence
(BPS) (5). In Metazoans, these four splicing signals alone
are not suﬃcient to direct splicing. Cis-acting exonic and
intronic splicing regulatory elements (ESRs/ISRs), recog-
nized by trans-acting factors such as SR and hnRNPs
proteins, modulate exon selection and regulate alternative
splicing (6,12).
With 1.07 million copies, Alu elements are the most
abundant repetitive element in the human genome,
composing more than 10% of the genome (3,13). Alus
belong to the SINE (short interspersed elements) family of
repetitive elements and are unique to primates (14,15).
The genomic distribution of Alu elements is non-uniform,
with a strong bias towards gene-rich regions and a
tendency to reside within intronic sequences (there are
718 460 intronic Alus within human protein-coding genes)
(13,16). The ﬁrst Alu sequence is thought to have been
formed by dimerization of two distinct Alu monomers
(Fossil Left and Right Alu Monomers, FLAM and
FRAM) that arose from a 7SL RNA gene (17,18).
A typical Alu is  300nt in length, consisting of two
similar, but distinct monomers—the left and the right
arms—joined by an A-rich linker and followed by a
poly(A) tail. The right arm contains a 31-bp insert that is
not present in the left arm, whereas the left arm contains
an internal promoter for RNA polymerase III (A and B
boxes) that is absent from the right arm (19,20) (see also
Figure 1A). These internal promoter elements signiﬁcantly
diﬀer from the consensus sequence, therefore eﬃcient
transcription of Alu elements is dependent on sequences
ﬂanking their site of insertion and the state of Alu
methylation (21–25). Although dimeric Alu elements are
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rodent genomes. B1 elements are monomeric Alu
sequences that originated from FLAM and have reached
a copy number of 500 000 in the mouse genome (13).
Approximately 5% of the alternatively spliced internal
exons in the human genome (exons that are ﬂanked by
an intron on both ends) are derived from Alu elements
(26,27). Alu-derived exons originate from intronic Alu
sequences by a process denoted ‘exonization’ (13,28–30).
Throughout evolution, some of these intronic Alus
accumulated mutations that led the splicing machinery
to select them as internal exons. Previous studies have
indicated that the majority of the Alu-derived exons are
alternatively spliced (13,31). This enriches the human
proteome with new isoforms without compromising its
integrity (32). However, mutations leading to constitutive
activation of Alu exons are prone to be deleterious due to
the loss of the transcript encoding the original form of the
protein and may result in a genetic disorder such as Alport
and Sly syndromes or OAT deﬁciency (33–35).
Alus can undergo insertion into introns in the sense or
antisense orientation relative to the coding sequence; in
the human genome, 55% are in the antisense and 45% in
the sense orientation (13,29). However, the majority of Alu
exons ( 85%) originate from Alus in the antisense
orientation and in most cases the right arm rather than
the left arm is the one selected for exonization (13,26).
We have recently shown that the exonization level of Alu
elements is almost three times higher than that of other
retroelements (e.g. LINE, MIR and CR1) in the human
genome and that it is also higher than that of the B1
retroelement (the monomeric form of Alu) in the mouse
genome (13). Therefore, retroelements have a greater
eﬀect on the human transcriptome in comparison to the
mouse transcriptome, due to the exonization of Alu
elements as internal exons that are alternatively spliced.
We therefore set out to examine why the right arm of
the dimeric Alu element is prone to alternative splicing.
Here we show that the left arm, the one that remains
intronic, is involved in the splicing regulation of the Alu
right arm exon. Deletion of the intronic left arm of the Alu
element resulted in exonization that was constitutive; this
can be detrimental as the original protein isoform is no
longer produced. The eﬀect of the left arm is independent
of the sequence of the right arm. Insertion of the left arm
downstream of another exon confers upon it alternative
splicing. The selective advantage of alternative splicing of
Alu exons by keeping the original transcript as a major
product is discussed.
MATERIALS AND METHODS
Compilation of right arm exonization dataset
A typical exonization of an Alu element occurs from a
right arm in the antisense orientation, as observed for the
ADAR Alu exon. We have compiled a dataset of Alu
elements that have undergone exonization in the antisense
orientation by querying the TranspoGene database (36).
This query yielded 744 exonized Alu sequences that
overlap with EST sequences. Since a typical Alu is
 300nt in length, we next ﬁltered out all Alus shorter
than 250nt, leaving 459 sequences. We used a simple
algorithm to detect the border between the two Alu arms:
We searched for the ﬁrst stretch of four consecutive Ts
(TTTT) between positions 120 and 200 of the Alu
sequence. Visual inspection established that this algorithm
correctly found the border between the left and right arms.
We next demanded that both the 50 and 30 exon borders,
as indicated by the supporting ESTs, were upstream of
this polyT stretch, thereby creating our initial right arm
dataset containing 342 sequences. Finally, we searched for
putative splicing signals in the left arm and ﬁltered out 12
cases in which either a putative 50ss or a putative 30ss
Figure 1. Characteristics of Alu right arm exons and their counterpart
intronic left arms. (A) Alignment of the right and left arm of AluJ
consensus sequence (gi551536) in its antisense orientation (relative to
the mRNA) using the MAVID alignment server (73). The PPT of the
right arm was extended to 19nt as, on average, the PPT length in
exonized Alus is 19 bases  3 (28) and is marked by horizontal brackets.
The major 30ss and 50ss that are selected by Alu exons are indicated
by arrows. Identical sequences are highlighted in gray. The 31-nt
sequence that is present only in the right arm is indicated in a box.
(B) Comparison of splice signals in the right and the left arms of 330
Alus that have undergone exonization originating from the right arm in
the antisense orientation. Boxes indicate right and left arms. Locations
of the real and putative splice sites are marked by arrowheads.
Distribution of ESEs, based on ESEﬁnder, throughout the exon and the
putative splice sites in the left arm are shown by a histogram divided
into four bins, each of which represents a quartile of the exon length.
The number in the center of the boxes represents the mean ESE density
score based on ESEﬁnder. (C) Comparison of ESR densities between
the right and left Alu arms. ESR densities are shown for three ESR
datasets: ESEﬁnder (38), Goren et al. (39) and Fairbrother et al. (40).
Nucleic Acids Research, 2008, Vol. 36, No. 6 2013(or both) could not be found in this arm. Our ﬁnal dataset
contained 330 Alu sequences.
The presented scores of the 50ss and 30ss were calculated
using Analyzer Splice Tool (http://ast.bioinfo.tau.ac.il/
SpliceSiteFrame.htm), which is based on procedures
described by Shapiro and Senapathy (37). Splicing signals
in the left arm were found using the following steps:
(i) beginning 8nt prior to the detected polyT, 30 running
windows of 15nt in length were given 30ss scores.
The value of 8nt was chosen so as to allow the identiﬁed
4-nt polyT stretch to serve as the last four positions
preceding the 30ss AG dinucleotide. The highest scoring
15-nt window was chosen as the 30ss. (ii) Beginning at a
distance of 23-nt downstream to the detected 30ss until the
end of the Alu sequence, running windows of 9nt were
given 50ss scores. The value of 23 was chosen to force the
minimal distance between the 30ss and the 50ss to be 25,
which is the minimal exon length in Alu right arm. The
highest scoring window was chosen as the 50ss.
ESRdensities
We searched for ESRs in right and left arms, between the
30ss and 50ss. Three sets of ESRs were used in this analysis:
(i) those obtained from the position-speciﬁc weight
matrices in ESEﬁnder (38) using the default thresholds;
(ii) all ESRs obtained by Goren et al. (39); and (iii) all
ESEs obtained by Fairbrother et al. (40). For each right
and left Alu arm in each ESR dataset, ESR density scores
were calculated. The ESR density score was calculated as
the number of nucleotides within a sequence covered by an
ESR, divided by the length of the sequence. Mann–
Whitney tests were used to compare the distributions of
ESR densities between the right and left arms.
Plasmid construction
The desired minigenes were generated by amplifying
human genomic fragments using primers containing an
additional sequence-encoding restriction enzyme sites.
The PCR products were restriction digested and inserted
into the pEGFP-C3 plasmid (Clontech), which contains
the coding sequence for Green Fluorescent Protein (GFP).
The ADAR2 minigene (adenosine deaminase), containing
the human genomic sequence of exons 7, 8 and 9 (2.2kb),
and the IMP minigene (IGF-II m-RNA-binding protein)
with the human genomic sequence of four constitutive
exons 10–13 (2.6kb) were previously cloned (28,41). For
the sequences of the minigene inserts see Supplementary
Data.
Minigenemutagenesis
Site-directed mutagenesis was carried out to introduce
mutations into the wild-type minigene by PCR using
oligonucleotide primers containing the desired mutations.
Mutations creating deletions in wild-type minigenes
were performed by PCR using 50 phosphorylated
primers ﬂanking the sequence to be deleted (see
Supplementary Data for list of primers). PCR was
performed using Pfuturbo DNA polymerase (Stratagene)
with an elongation time corresponding to 2min for each
kilo base. The PCR products were treated with DpnI
(20U, New England BioLabs) at 378C for 1h. Plasmid
mutants were ligated using T4 DNA Ligase (New England
BioLabs) at 378C for 2h. Mutant plasmids were trans-
formed into Escherichia coli XL1-competent cells. DNA
was extracted from selected colonies by mini-prep extrac-
tion (Promega). All plasmid sequences were conﬁrmed by
standard sequencing.
Transfection, RNA isolationand RT–PCR amplification
Culturing of 293T cells in Dulbecco’s Modiﬁcation of
Eagle medium was supplemented with 4.5g/ml glucose
(Biological Industries, Inc.), 10% fetal calf serum (FCS),
100U/ml penicillin, 0.1mg/ml streptomycin and 1U/ml
nystatin (Biological Industries, Inc.). Cells were cultured
in 6-well plates under standard conditions at 378Ci n5 %
CO2. Cells were grown to 60% conﬂuence and transfec-
tion was performed using 3ml FuGENE6 (Roche) with
1mg of plasmid DNA. RNA was isolated and harvested
after 48h. Total RNA was extracted using Trizol Reagent
(Sigma), followed by treatment with 1U RNase-free
DNase (Ambion). RT–PCR ampliﬁcation was preformed
for 1h at 428C, using an oligo dT reverse primer and 2U
reverse transcriptase of avian myeloblastosisvirus (AMV,
Roche). The spliced cDNA products derived from the
expressed minigenes were detected by PCR. For both
minigenes (ADAR2 and IMP), we used the pEGFP-
speciﬁc reverse primer (
50
CGCTTCTAACATTCCTAT
CCAAGCGT
30
) for ampliﬁcation. For the forward
primers, we used an ADAR2 exon 7 primer (
50
CCC
AAGCTTTTGTATGTGGTCTTTCTGTTCTGAAG
30
)
and an IMP exon 9 primer (
50
AATCTTACTCATGTTA
CTA
30
). Ampliﬁcation was performed for 28 cycles to
maintain a linear relationship between the RNA input and
signal (39). Each cycle consisted of 30s at 948C, 45s at
618C and 1.5min at 728C. The RT–PCR products were
separated on a 2% agarose gel and conﬁrmed by
sequencing. Using the TOPO TA Cloning kit (invitrogen),
we found that both the proximal and the distal AG of the
Alu right arm exon were selected (28). The relative ratios
of RNA products were measured using ImageJ software
(http://rsb.info.nih.gov/ij/index.html), as we found pre-
viously that ImageJ quantiﬁcation for ADAR2 RT–PCR
products correlates with real-time RT–PCR quantiﬁcation
produced by the Roche LightCycler PCR and detection
system (28). The level of mRNA of the housekeeping gene,
glyceraldehyde-3-phosphate dehydrogenase, was used as
the internal control for each transfection.
RESULTS
Alu exons arestronger insplicing potential thantheir
counterpart intronic arms
The right and left arms of Alu are highly similar, sharing
 80% sequence identity after excluding the 31-bp inser-
tion in the right arm (Figure 1A). Despite this sequence
similarity, most exonizations occur in right arms of Alu
elements inserted in the antisense orientation relative to
the mRNA precursor. We ﬁrst set to examine the presence
and strength of the splice signals in the left and right arms.
We thus compiled a dataset of Alus that have undergone
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for potential splicing signals and ESR densities within
the left arm. Speciﬁcally, we searched for optimal 30 and
50 splice sites with a minimum of 25nt between them,
chosen because the shortest Alu exon in this dataset is
25nt. Following these ﬁltrations, 330 Alus remained in
this dataset (see ‘Materials and Methods’ section for
details).
We found that the left arms, although not exonized,
contained putative PPT-30ss and putative 50ss. However,
the 50 and the 30 splice sites in the exonized right arms were
stronger, in a statistically signiﬁcant manner, than in the
nonexonized counterpart (Figure 1B). Based on the
Shapiro and Senapathy scoring method (42), the mean
30ss in the right arm exon was 86.87, compared to 86.01 in
the left arm (Mann–Whitney, P=0.0485). The mean 50ss
in the right arm exon was 76.71, compared to 70.99 in the
left arm (Mann–Whitney, P=2.7e–019). Using diﬀerent
scoring methods for measuring the strength of the splice
sites did not alter our conclusions.
We next compared the ESR densities in the two Alu
arms. In this analysis we used three diﬀerent sets of ESRs:
(i) those obtained from the position-speciﬁc weight
matrices in ESEﬁnder using the default thresholds (38);
(ii) all ESRs compiled by Goren et al. (39); and (iii) all
ESEs obtained by Fairbrother et al. (40). For each right
and left Alu arm in each of the three ESR datasets, we
calculated the ESR densities. The ESR density score was
calculated as the number of nucleotides within a sequence
covered by an ESR, divided by the length of the sequence.
Figure 1C shows that all three analyses revealed that the
right arm was enriched with ESRs compared to the left
arm. Namely, the ESR densities of ESEﬁnder, Goren et al.
and Fairbrother et al. were 0.74, 0.49 and 0.13,
respectively, in the right arm, but only 0.58, 0.40 and
0.11 in the left arm, respectively, with these diﬀerences
being highly signiﬁcant (Mann–Whitney, P   0, P   0 and
P=6.43e–004, respectively). To examine whether any of
the two Alu arms has a better potential to serve as an
intron, we compiled a dataset of 10 experimentally
validated binding sites, comprising binding sites of nine
hnRNP proteins and Fox1 protein (extracted from http://
ast.bioinfo.tau.ac.il/ESR.htm). We found a signiﬁcantly
higher density in the left arm compared to the right arm
(density in right arm: 0.0531, density in left arm: 0.0628;
Mann–Whitney P-value: 4.11e–5). These ﬁndings may
suggest that not only does the right arm have a better
potential to serve as an exon, the left arm is more suitable
to serve as an intron, as well. However, comparison of
the densities of ISRs in both Alu arms based on two
computationally predicted datasets of Yeo et al. (43) and
Voelker et al. (44) yielded contradictory results: the former
indicated higher ISR densities in the right arm, while
according to the latter the ISR density was higher in the
left arm (data not shown).
These results indicate that the left arm has a lower
potential for exonization, as these arms are characterized
by weaker splice sites and lower ESR densities than the
exonized right arms. Thus, in cases of Alu exonizations,
the right arm Alu exon is accompanied by an intronic Alu
arm that has the characteristics of an exon (potential
splice sites) but is a weaker candidate for exonization.
The intronic left arm ofthe Alu element promotes
alternative splicing of upstream exons
To determine whether the intronic left arm of the Alu
elements has a role in regulating the exonization of the
right arm we deleted the entire intronic left arm of an Alu
element in ADAR2 (adenosine deaminase) minigene.
Exon 8 of the ADAR2 gene is an Alu exon that is
alternatively spliced. This exon adds 40 amino acids in
frame to the protein (45). Exon 8 of the ADAR2 gene is
representative of most Alu exonizations events reported to
date, that is, exonizations of the right arm of an antisense
Alu. Also, the left arm of this Alu element is generally
weaker than the right exonized arm in terms of splice site
strengths and ESR density, although the 50ss of the
exonized arm is weaker than that of the unexonized arm
(Figure 2A). We therefore generated a minigene contain-
ing exons 7–9, and the introns in between, of the human
ADAR2 gene (13,26). The minigene was transfected into
293T cells, total cytoplasmatic RNA was extracted and
the splicing pattern was examined by RT–PCR using
speciﬁc primers to the minigene mRNA.
The wild-type Alu exon was included in 64% of the
transcripts (Figure 2B, lane 2). However, deletion of the
intronic left arm resulted in a shift from alternative to
constitutive inclusion of the Alu exon (Figure 2B, compare
lanes 2 and 3). This suggests that the left arm in the
antisense orientation is essential for alternative selection
of the right arm.
To examine if the left arm of the Alu element promotes
alternative splicing, we inserted it downstream of a non-
Alu exon, exon 12 of IMP, that is known to be
constitutively spliced (41). Remarkably, this insertion
resulted in a shift from constitutive to alternative splicing
of this exon (Figure 2C, compare lanes 1 and 2). As a
control, the sequence was inserted in the sense orientation
and had no eﬀect on splicing of exon 12 (Figure 2C,
lane 3). This indicates that the sequence of the left arm
itself, and not a speciﬁc sequence that was interrupted by
the insertion, was responsible for the shift from constitu-
tive to alternative splicing. Insertion of the left arm
upstream of the constitutive exon had a much weaker
eﬀect on the pattern of splicing and caused a slight shift
from constitutive to alternative splicing. This slight eﬀect
was abolished when the sequence was inserted in the sense
orientation (Figure 2C, lanes 4 and 5). Taken together,
these results imply that the left arm of the Alu element in
the antisense orientation, when located downstream of an
exon, enhances alternative selection of the upstream exon.
This allows expression of both the original transcript as
well as that including the Alu exon, thus providing an
advantage for Alu elements, making them more favorable
candidates for exonization (see ‘Discussion’).
To identify sequence determinants in the intronic left
arm that are responsible for the shift from constitutive to
alternative splicing of the Alu right arm exon, we began by
eliminating the three main potential splice signals within
the intronic left arm: the putative PPT (pPPT), putative
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The mutations were made such that the two consecutive
potential 30ss and 50ss that exist in the left arm were
eliminated (AGAG to ACCG and GTGT to GAAT; see
Supplementary Data for primers). Deletion of the pPPT
sequence or the elimination of the two potential 30ss in the
intronic left arm (AGAG to ACCG) had a minor eﬀect on
the level of alternative splicing of the Alu exon (Figure 2B,
lanes 4 and 5). However, the combination of both
mutations resulted in a strong shift toward constitutive
inclusion (Figure 2B, lane 6). Mutations of the p50ss alone
or in combination with other putative splicing signals
yielded puzzling, yet consistent results. Mutation of the
p50ss consistently did not aﬀect the alternative selection of
the upstream Alu exon. Moreover, the shift toward
constitutive splicing that was demonstrated by combined
mutations of the pPPT and p30ss was abolished when we
further mutated the p50ss, leading to alternative splicing
(Figure 2B, lanes 7–10). The above results are suggestive
of a complex regulatory role for the intronic left arm. The
most dramatic eﬀect occurred when the potential pPPT
and p30ss were both eliminated. However, even in this case
the inclusion rate increased only to 85% and not to the
100% inclusion rate as obtained after deletion of the entire
left arm, suggesting that additional sequences along the
left arm are also involved in the regulation of alternative
splicing preventing constitutive inclusion of the Alu right
arm exon.
The intronic left arm can exonize
The high sequence similarity between the two arms
(Figure 1A) led us to examine whether the intronic left
arm can undergo exonization. Deletion of the exonized
right arm did not bring about exonization of the intronic
left arm (Figure 2D, lane 3). This indicates that even in the
absence of the competing right arm, the splicing signals in
the left arm are insuﬃcient to direct splicing. In the
majority of pathological pseudo-exon inclusion events,
a5 0ss creation or activation occurs (46). We thus
hypothesized that a stronger 50ss would be less sensitive
to the negative context that prevents the left arm from
being exonized (47). We strengthened the p50ss of the left
arm by mutating it from CAG/gtgtgt to CAG/gtaagt
Figure 2. The intronic left arm of the Alu element is essential for the
alternative splicing of an upstream exon. (A) The sequence of an Alu
retroelement in its antisense orientation from which exon 8 of ADAR2
is exonized. The right arm (in red) undergoes exonization while the
left arm (in blue) is intronic. The potential PPT, 30ss, and 50ss in the
left arm (unexonized) are underlined. ESE densities (according to
ESEﬁnder) for each arm are indicated on the right. (B) Plasmids
containing the indicated mutants were transfected into 293T cells. Total
cytoplasmic RNA was extracted, and splicing products were separated
in 2% agarose gel after reverse transcription polymerase chain reaction
(RT–PCR). Lane 1, vector only (pEGFP); lane 2, splicing products of
wild-type ADAR2; and lanes 3–10, splicing products of ADAR2
minigene mutated at the left arm of the Alu element in diﬀerent
combinations. LA: deletion of the entire intronic left arm; pPPT:
deletion of the 14-bp pPPT sequence of the left arm; p30ss:
elimination of two potential 30ss in the intronic left arm (AGAG to
ACCG); p50ss: elimination of two potential 50ss in the intronic left
arm (GTGT to GAAT). The two possible minigene mRNA isoforms
are shown on the right. The numbers above the lanes indicate exon 8
inclusion level. (C) Insertion of an intronic left arm of an Alu element
downstream to a constitutive exon results in a shift toward alternative
splicing. The sequence of the intronic left arm of the Alu element,
from which exon 8 of ADAR2 gene undergoes exonization (in its
antisense orientation), was cloned downstream to constitutive exon 12
in the IMP minigene. The splicing assay was performed as described
above. Lane 1, splicing product of wild-type IMP; lanes 2–3, splicing
products of IMP minigene in which the intronic left arm of the Alu
element from ADAR2 was inserted downstream to exon 12 in antisense
and sense orientations, respectively; lanes 4–5, splicing products of IMP
minigene in which the intronic left arm of the Alu element from
ADAR2 was inserted upstream to exon 12 in antisense and sense
orientations, respectively. The two possible minigene mRNA isoforms
are shown on the right. The numbers above the lanes indicate exon 12
inclusion levels. (D): Exonization of the intronic left arm. Splicing
assays were performed as described above. Lane 1, splicing products of
wild-type ADAR2; lane 2, splicing products of ADAR2 mutant
harboring a deletion of the intronic left arm; lane 3, splicing products
of ADAR2 mutant harboring a deletion of the exonized right arm;
lane 4, splicing products of ADAR2 mutant after strengthening of the
p50ss and pPPT of the intronic left arm; lane 5, splicing products of
ADAR2 mutant harboring a replacement of the intronic left arm with
the sequence of an additional right arm. The two minigene mRNA
isoforms are shown on the right and were conﬁrmed by sequencing.
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the p50ss alone was not suﬃcient to switch Alu exon
selection from the right to the left arm (data not shown).
Previous studies have shown that pseudo-exon activation
or Alu exonization are not achieved by the combined
strengthening of the 50ss and 30ss alone (48,49). We
therefore strengthened both the pPPT (to 17 consecutive
uridines, similar to the functional PPT of the right arm)
and the p50ss. These combined changes enabled selection
of the left arm rather than the right arm and facilitated
exclusive, albeit alternative, exonization of the left arm
(Figure 2D, lane 4; RT–PCR products were conﬁrmed by
sequencing and revealed that the proximal p30ss, TAG,
was selected). This exonization did not occur when the
pPPT was strengthened alone (data not shown). This
result suggests that the intronic left arm is a few steps
away from splicing competence, and thus might act as a
pseudo-exon that competes with the right arm.
Our bioinformatic analysis showed that in most cases of
Alu exonizations, the Alu exon is accompanied by an Alu
arm that has the characteristics of a weak exon.
To examine whether the splicing signals in the right arm
must be stronger than those in the left arm for alternative
exonization of the Alu exon, we substituted the intronic
left arm with a right arm, thus producing a mutant
minigene in which two identical arms of equal strength
were located one after the other. We inserted a point
mutation in right arm duplicate (the left position) in order
to identify by sequencing which arm underwent exoniza-
tion (see Supplementary Data). Competition between two
exons resulted in a reduction in the total amount of
mature mRNA (Figure 2D, lane 5). Sequencing of the
PCR products revealed that each exon was selected
separately, with a slight preference for the downstream
exon.
The intronic left arm of theAlu element functions as aunit
We then examined the eﬀect of the distance between
the two arms on alternative selection of the right arm.
We inserted a 350-bp sequence originating from intron 11
of the IMP gene into four diﬀerent positions: (a) between
the exonized right arm and the intronic left arm;
(b) between the pPPT and the p30ss of the intronic left
arm; (c) in the center of the intronic left arm; and
(d) downstream of the intronic left arm (Figure 3A).
Insertion into site ‘a’ separates the left from the right arm
as a complete unit; insertion into sites ‘b’ and ‘c’ leaves
part of the intronic left arm in the same distance from the
Alu exon and separates only the downstream parts of
the left arm from the right while insertion into site ‘d’
leaves the left arm intact. Insertion of a 350-bp fragment
into sites ‘a’, ‘b’ or ‘c’ resulted in higher levels of exon
inclusion than in the wild-type construct (Figure 3B,
lanes 2–4), whereas insertion downstream of the left arm
(site d) had a minor eﬀect, if any, on splicing (Figure 3B,
lane 5).
The two arms are separated by a sequence of 40bp
(including the pPPT of the left arm). To further evaluate
the importance of the distance between the two arms for
the splicing of the right arm, we increased this distance by
inserting sequences of growing lengths between the right
and left arms. We used ESEﬁnder to ensure that the
inserted sequence did not contain putative ESEs [(38) see
also Supplementary Data]. As shown in Figure 3C, lanes
1–4, increasing the distance between the two arms from
40 to 70bp had a minor eﬀect on the inclusion level.
However, when the distance between the two arms was
80bp or longer there was a shift toward higher levels of
inclusion (Figure 3C, lanes 5–11). We thus concluded that
the eﬀect of the intronic left arm on the splicing of the
right arm is distance dependent. Once the distance
between the two arms increased to over 70bp, the eﬀect
of the left arm on the inclusion level of the right arm
decreased considerably. Taken together, the data in
Figures 2 and 3 indicate that the intronic left arm
functions as a unit and diﬀerent elements along the left
arm must be present within a certain distance from the
right arm to promote alternative splicing.
Figure 3. Increasing the distance between the left and right arms of
the Alu element results in a shift toward constitutive splicing.
(A) Illustration of the Alu element in its antisense orientation.
The right and left arms are marked by horizontal brackets. An intronic
sequence of 350bp was inserted in four diﬀerent positions along the
intronic Alu’s left arm: (a) between the exonized right arm and the
intronic left arm; (b) between the pPPT and the p30ss of the intronic left
arm; (c) in the center of the intronic left arm; (d) downstream of the
intronic left arm. (B) Splicing assays were performed as described in
Figure 2. Lane 1, splicing products of wild-type ADAR2; lanes 2–5,
splicing products of ADAR2 minigene mutated as indicated in A.
(C) Intronic sequences of growing lengths (10–300bp) were inserted
between the exonized right arm and the intronic left arm. Lane 1,
splicing products of wild-type ADAR2; lanes 2–11, splicing products of
ADAR2 minigene mutated as indicated.
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Mutations in the three main splice signals (pPPT, p30ss
and p50ss) located in the left arm were not suﬃcient to
induce constitutive splicing of the right arm, whereas
deletion of the entire left arm shifted splicing from
alternative to constitutive (Figure 2B). This implies
that other sequences in the left arm aﬀect splicing of the
right arm.
Previous analysis which compared the full-length Alu
sequence of right-arm exonizing Alus to nonexonizing
Alus did not reveal any regulatory positions along the
intronic left arm (29). To identify such sequences, we
systematically replaced segments of 25bp along the left
arm with a 25-bp sequence that did not contain any
potential splice signals or SR-binding sites (Figure 4A;
shown by underlined reps 1–5; see also Supplementary
Data). Replacement of segments 1, 2, 3 and 4 resulted in a
higher level of inclusion of the right arm than observed in
the wild-type construct (Figure 4B, lane 3, 4 and 6,
respectively), whereas replacement of the last segment,
which contains the p50ss, was similar to mutation of the
p50ss alone (compare Figure 4B, lane 6 with Figure 2B,
lane 7). Thus it appears that the elements involved in
regulation of the splicing of the Alu right arm exon are
spread throughout the entire intronic left arm.
To determine if the potential binding sites of SF2,
SRp40 located in segments 2 are involved in alternative
splicing of the Alu exon, we mutated each of the indicated
sites. Figure 4A illustrates the locations of the putative
binding sites along the intronic left arm that were mutated
(for a list of all ESRs that are present along the left arm
see Table S2 in the Supplementary Data). Elimination of
the potential SF2 and SRp40 sites in segment 2, without
creating a new putative SR-binding sites (according to
ESEﬁnder) or putative ESR sequences [according to
Goren et al. (39), Fairbrother et al. (40), Wang et al.
(50) and Zhang et al. (51)], did not aﬀect splicing
(Figure 4C, lanes 2 and 3). However, when these
mutations were combined with a deletion of the pPPT,
which by itself had a minor eﬀect on the splicing of the Alu
exon (see Figure 2B, lane 4), there was an increase in the
level of the Alu exon inclusion (Figure 4C, lanes 5 and 6).
These results indicate that some of the potential SR-
binding sites are functional ISRs that aﬀect splicing of the
upstream exon when combined with a deletion of the
pPPT.
In segment 5 there are three overlapping potential
binding sites for SF2 and SRp40 and SC35 located
immediately upstream of the potential 50ss. A high
concentration of ESRs upstream of a 50ss has been
shown to be important for splicing and exon selection
(39,52,53). Since the above results indicated that this
region was involved in the regulation of the exonization
of the upstream exon, we subjected the ESRs in this region
to further analysis. We designed mutations that aﬀected
the ESRs but not the p50ss (CAG/GTGTGA). Mutation
that eliminated SC35 alone had no eﬀect on the splicing
pattern of the Alu right arm exon (data not shown).
We therefore focused on SF2 and SRp40 putative
Figure 4. The eﬀect of pseudo splice signals and putative SR-binding
sites within the left arm on the splicing pattern of the right arm.
(A) Segments along the left arm 25bp in length (rep1–rep5) were
replaced with a designed sequence that did not contain any potential
splice signals or SR-binding sites. The examined putative ESRs are
shown. (B) Splicing assays were performed as described in Figure 2.
Lane 2, splicing products of wild-type ADAR2; lanes 2–6, splicing
products of ADAR2 minigene with replaced segments (rep1–rep5).
(C) Lane 1, splicing products of wild-type ADAR2; lanes 2–6, splicing
products of ADAR2 minigene mutated at the indicated binding sites in
segments 2, with and without deletion of pPPT. (D) Changes in the
binding capacities of putative SR proteins in segment 5 (near the
potential 50ss of the intronic left arm). Lane 1, splicing products of
wild-type ADAR2; lanes 2–8, splicing products of ADAR2 minigene
with the indicated mutations (see Supplementary Data).
2018 Nucleic Acids Research, 2008, Vol. 36, No. 6binding sites. We created two mutant minigenes that
harbor only SF2 or only SRp40-binding sites near the
p50ss with scores diﬀerent from those in the wild-type
sequence and an additional mutant minigene in which the
SRp40-binding site was weaker and the SF2 binding was
stronger than the original potential binding sites (see
Supplementary Data). Strengthening the SF2-binding site
alone resulted in a minor elevation of the inclusion level of
the Alu exon (Figure 4D, lane 3). This eﬀect was elevated
when the mutation was combined with the deletion of the
pPPT (Figure 4D, lane 7). When the binding aﬃnity of
SF2 site was strengthened and the potential SRp40 site
was weakened, the right arm exon was more frequently
skipped than in the wild-type construct (Figure 4D,
lane 4). This eﬀect was further enhanced when the
mutation was combined with the deletion of the pPPT
(Figure 4D, lane 8). In contrast, a mutation that slightly
decreased the binding aﬃnity of the SRp40 site, with and
without deletion of the pPPT, had no eﬀect on alternative
splicing of the Alu exon (Figure 4D, lanes 2 and 6). These
results further support our observations that ISRs in the
intronic left arm are functional, although unlike those in
segment 2, the exact roles of the putative SF2 and SRp40
sites in enhancing or repressing splicing of the Alu exon
were not conclusive. Altogether, these results show an
interplay between the pPPT and the functional ISRs.
We also examined whether the 31-bp sequence that is
absent in the left arm (see Figure 1A) can aﬀect Alu exon
selection or the pattern of splicing of the Alu exon.
Addition of this sequence to the left arm in a comparable
position to that in the right and deletion of it from the
right arm did not switch the Alu exon selection from
the right arm to the left arm nor did it aﬀect the pattern
of splicing of the Alu exon (see Supplementary Data
Figure 1S, lanes 2–4).
DISCUSSION
We have recently shown that the exonization level of Alu
elements is signiﬁcantly higher compared with other
retroelements in the human genome. In addition, we
have also shown that the exonization level of Alu elements
is almost three times higher than that of B1 retroelement
(the monomeric form of Alu) in the mouse genome even
though they share high levels of sequence similarity and
the same ancestral origin (7SL RNA) (13). Although Alu
elements are not enriched with pseudo-splice sites (13,54),
they exhibit a higher exonization rate compared to other
repetitive elements in the human genome. This raises the
intriguing question of what makes Alu elements more
potent for exonization. In this report we set out to
examine whether the high exonization capability of Alu
elements, which is mostly observed in the antisense
orientation (13,26), can be attributed to their unique
dimeric structure.
The ﬁrst indication that the nonexonized arm of Alu
maintains alternative rather than constitutive exon selec-
tion was observed upon its deletion, leading to a shift from
alternative to constitutive Alu exon selection (Figure 2B).
Moreover, when we placed the nonexonized arm
downstream to a constitutive exon, this exon was endowed
with alternative splicing. Taken together, these results
demonstrated that the left arm in the antisense orientation
enabled alternative rather than constitutive selection of an
upstream exon. In the case of newly emerged Alu exons,
this observation is most signiﬁcant since selection of an
Alu exon in a constitutive manner will generate only a new
transcript that may be deleterious, by causing a frameshift
or introducing a premature stop codon, as documented in
OAT deﬁciency and Alport and Sly syndromes (33–35).
However, splicing of an Alu exon in an alternative manner
can make such an exonization tolerable since it allows the
new variant to be evolutionarily tested while the original
transcript is expressed. Indeed, most of the Alu exons
maintain a low inclusion level, thus maintaining the
evolutionary conserved isoform as the major mRNA
template generated from the gene (13,31). In this way,
alternative splicing of Alu exons allows to increase
transcriptomic diversity with new isoforms without
compromising their original gene function as would
occur if Alu exons were exonized constitutively. For this
reason, newly born exons, and speciﬁcally newly born Alu
exons, are almost always alternatively spliced
(13,32,55,56).
A large-scale analysis of transposed elements in human
and mouse genomes revealed a 3-fold higher exonization
level of Alu elements in human, with respect to their
murine counterpart B1 (13). The most prominent feature
distinguishing Alu from B1 elements is the dimeric
structure of Alu, as opposed to the monomeric structure
of B1. Our results provide a possible explanation for
the higher exonization rate found in human, namely that
the intronic left arm of the Alu element facilitates
alternative rather than constitutive splicing of the exonic
right arm. This would decrease the evolutionary selection
pressure against Alu exons, thus enabling a nondeleterious
enrichment of the transcriptome.
By what mechanism does the left arm enable alternative
splicing of the upstream exon? One possible explanation is
that this region forms a secondary structure that impairs
the ability of the splicing machinery or other regulatory
proteins to correctly identify the exon (57,58). Alu RNAs
are known to have a distinct secondary structure (59).
Indeed, we found that deletion of the left arm caused
considerable change in the minimal free energy of
the predicted secondary structure of the ADAR Alu
according to RNAfold program [(60) see Supplementary
Data, Table S3]. However, we could not ﬁnd a general
correlation between strength of predicted secondary
structure and splicing patterns. For example, upon
insertion of the Alu left arm downstream of the IMP
exon in either sense or antisense orientation, the predicted
minimal free energy of the region decreased considerably.
However, the splicing pattern of the IMP exon following
insertion of left arm in sense or antisense orientations was
completely diﬀerent (constitutive versus alternative,
respectively). We also visually examined the predicted
secondary structures of the various mutants and could not
observe a consistent correlation between changes in
secondary structures and in splicing patterns. These results
imply that while the secondary structure of the left arm of
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splicing of the IMP exon, it is not an exclusive factor.
Another possible explanation for the ability of the left
arm to weaken the selection of the Alu exon, manifested
by the shift towards alternative splicing, is that the left
arm acts as a ‘pseudo-exon’ competing with the right arm
for spliceosome components. This model was motivated
by results showing that tandemly duplicated exons are
mostly spliced in a mutually exclusive fashion. Work by
Letunic et al. (61) showed that when two exons are located
in close proximity, one exon suppresses the selection of the
other. Indeed, our bioinformatic analysis showed that the
exonized arm tends to be characterized by stronger
splicing signals than the intronic counterpart. These
results are in line with the ﬁnding of Sironi et al. (54)
who showed that pseudo-exons display, on average,
weaker splice site consensuses and lower ESE frequencies
than real exons and are suggestive of such a model in
which the exonized (in our case right) arm contains
suﬃcient signals required for its selection, while the
nonexonized arm (in this case left) contains most, but
not all, splicing signals. Figure 5 illustrates this possible
model of competition between the two arms: When the
Alu right arm exon competes with a weaker ‘pseudo-exon’
for spliceosome components, it reduces selection of the
right arm as an exon and the right arm is alternatively
spliced; however, when the Alu right arm exon is free of
left arm regulation it is constitutively spliced.
Our ﬁndings, however, indicate that a simple model of
competition cannot fully account for the regulation
exerted by the left arm on the alternative splicing of the
Alu exon. This was shown when all three main potential
splice signals in the left arm were mutated, and the
alternative splicing pattern of the Alu exon was unaﬀected.
However, a combination of mutations of the pPPT and
the p30ss had a dramatic eﬀect on splicing, shifting exon
selection from alternative to almost constitutive inclusion.
This almost constitutive inclusion was reversed to alter-
native splicing when pPPT and p30ss mutations were
combined with a p50ss mutation. This combination
between two sites to exert an eﬀect on splicing that was
stronger than the eﬀect of each splice signal alone was also
observed when the putative SR-binding sites in the left
arm were mutated in combination with the pPPT. This
indicates that the shift toward constitutive splicing
observed upon deletion of the entire intronic left arm
was not due to the eﬀect of each splice signal alone but
rather due to interplay among several signals located
along the left arm.
The synergistic activity of the PPT and the 30ss is not
surprising. Indeed, in the course of the splicing reaction,
U2AF65 and U2AF35 bind cooperatively to the poly-
pyrimidine tract and to the 30ss AG dinucleotide,
respectively (62,63). This process is highly regulated and
recent work by Soares et al. (64) demonstrated that
phosphorylated DEK, a chromatin and RNA associated
protein, facilitates 30ss recognition by U2AF35 and
prevents binding of U2AF65 to pyrimidine tracts not
followed by AG. Thus, our results provide a further
example for the joint function of the PPT and the 30ss.
How does the PPT mediate its eﬀect? It has been
reported that pyrimidine-rich motifs have an inhibitory
eﬀect on splicing in the human genome (65). This,
however, was shown to be the case when the pyrimidine-
rich motifs were inserted into a central exon of a three-
exon minigene model, whereas in our case the pPPT is
Figure 5. Why are Alu exons alternatively spliced? (A) The splicing pattern of exonization events originating from the right arm of Alu elements
(ExonRA) is alternative due to the presence of a downstream arm that presumably acts as a pseudo-exon. Thus, competition between two highly
similar arms shifts the splicing pattern of the stronger arm to alternative. Although the weaker left arm does not undergo exonization, it nonetheless
participates in the regulation of the stronger right arm by reducing the aﬃnity of the splicing machinery for the exonized arm, thereby causing it to
be alternatively spliced. (B) However, when the exonized right arm (ExonRA) is free of left arm regulation it is constitutively spliced. Such events are
presumably deleterious, and therefore may be selected against.
2020 Nucleic Acids Research, 2008, Vol. 36, No. 6located downstream of the aﬀected exon. PPTs, located in
introns, are also known to regulate inclusion levels of
upstream exons. Diﬀerent proteins are known to bind
such intronic PPTs, including U2AF65, TIA-1 and PTB
(66–68). U2AF and TIA-1 both promote the recruitment
of U1 snRNP to weak 50ss that are followed by uridine-rich
sequences, whereas PTB is known to antagonize the action
of TIA-1 and U2AF and induce exon skipping (67,69–71).
In the Alu exon, the pPPT of the intronic left arm appears
downstream of the 50ss. This raises the possibility that
factors such as U2AF65, TIA-1 andPTB may play arole in
splicing regulation of the Alu exon. In this context, two
points are noteworthy: (i) The pPPT does not contain a
consensus PTB-binding site [consensus UCUU/C within a
pyrimidine-rich context (66,72)]. However, due to the
degeneracy of the PTB-binding sites, PTB may nonetheless
be involved in the Alu exon regulation. (ii) The eﬀect of
U2AF and TIA-1 on 50ss usage has been reported in cases
in which the PPT was located immediately downstream of
the 50ss (69,70). However, interaction of TIA-1 was also
shown to occur even when the PPT was more than 30-bp
downstream of the 50ss (71). A secondary structure formed
in the pre-mRNA or involvement of other splicing factors
may facilitate the action of TIA-1 or the RS domain of
U2AF65 in cases in which the PPT is not located
immediately after the 50ss. In the present case of Alu
exonization, we ﬁnd it very unlikely that the pPPT
functions solely to mediate binding of TIA-1 or PTB;
rather it is more likely to function in conjunction with the
downstream p30ss to facilitate pseudo-exon recognition, in
which the downstream p50ss and several SR-binding sites
are involved.
We also showed that when two identical arms are
located adjacent to each other and both have the potential
to exonize, the overall eﬀect is to decrease the selection
of the exon and the levels of cytoplasmic mRNA. In
our assay, either exon could be selected with a slight
preference for the downstream exon. Thus, competition
between two active exons of identical strength presumably
disrupts mRNA splicing. A similar mechanism was
suggested for mutually exclusive spliced exons that
originate from exon duplication, in which only one exon
is selected within a given mRNA, but never are both
spliced into the mRNA (61). Our results experimentally
validate this hypothesis and further imply that such
competition between adjacent, identical exons imposes a
problem for the splicing machinery and presumably leads
to lower levels of splicing and hence to lower levels of
mature mRNA.
To summarize, we have shown that the right arm Alu
exons are accompanied by weaker competitors on the left
arm and that the dimeric structure of the Alu element
enables alternative rather then constitutive splicing of the
Alu exon, thereby leading to the enrichment of the human
transcriptome with new isoforms while preserving the
original transcriptomic repertoire.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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